These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28234628)

  • 21. [Intracochlear drug delivery in combination with cochlear implants : Current aspects].
    Plontke SK; Götze G; Rahne T; Liebau A
    HNO; 2016 Nov; 64(11):797-807. PubMed ID: 27757480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of gene therapy for inner ear disease: Using bilateral vestibular hypofunction as a vehicle for translational research.
    Staecker H; Praetorius M; Brough DE
    Hear Res; 2011 Jun; 276(1-2):44-51. PubMed ID: 21251965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status and prospects of gene therapy for the inner ear.
    Sun H; Huang A; Cao S
    Hum Gene Ther; 2011 Nov; 22(11):1311-22. PubMed ID: 21338273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inner ear therapy for neural preservation.
    Richardson RT; Noushi F; O'Leary S
    Audiol Neurootol; 2006; 11(6):343-56. PubMed ID: 16988498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials for inner ear drugs: Design and execution challenges.
    Jung DH; Rauch SD
    Hear Res; 2018 Oct; 368():123-126. PubMed ID: 29602591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.
    Nyberg S; Abbott NJ; Shi X; Steyger PS; Dabdoub A
    Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methods of gene therapy for inner ear diseases].
    Li S; Zhu H; Wang X; Liu H; Huang Y; Yao X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Oct; 16(10):546-9. PubMed ID: 15515568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro and in vivo studies on hydroxyapatite nanoparticles as a novel vector for inner ear gene therapy].
    Sun H; Jiang M; Zhu SH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan; 43(1):51-7. PubMed ID: 18357714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of intracochlear drug delivery devices in the management of inner ear disease.
    Ayoob AM; Borenstein JT
    Expert Opin Drug Deliv; 2015 Mar; 12(3):465-79. PubMed ID: 25347140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel controlled local drug delivery system for inner ear disease.
    Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
    Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for clinical and experimental interventions for repair and regeneration in the inner ear.
    Raphael Y
    Adv Neurol; 1997; 72():163-9. PubMed ID: 8993696
    [No Abstract]   [Full Text] [Related]  

  • 32. Minimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membrane.
    Buckiová D; Ranjan S; Newman TA; Johnston AH; Sood R; Kinnunen PK; Popelář J; Chumak T; Syka J
    Nanomedicine (Lond); 2012 Sep; 7(9):1339-54. PubMed ID: 22475648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical aspects of inner ear gene delivery for research and clinical applications.
    Lee S; Dondzillo A; Gubbels SP; Raphael Y
    Hear Res; 2020 Sep; 394():107934. PubMed ID: 32204962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A state-of-the-art analysis of pharmacological delivery and artificial intelligence techniques for inner ear disease treatment.
    Li W; Zheng N; Zhou Q; Alqahtani MS; Elkamchouchi DH; Zhao H; Lin S
    Environ Res; 2023 Nov; 236(Pt 1):116457. PubMed ID: 37459944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physico-chemical characterization of liposomes and drug substance-liposome interactions in pharmaceutics using capillary electrophoresis and electrokinetic chromatography.
    Franzen U; Østergaard J
    J Chromatogr A; 2012 Dec; 1267():32-44. PubMed ID: 22824223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [1D-and 3D- computer simulation for experimental planning and interpretation of pharmacokinetic studies in the inner ear after local drug delivery].
    Plontke S; Siedow N; Hahn H; Wegener R; Zenner HP; Salt AN
    ALTEX; 2004; 21 Suppl 3():77-85. PubMed ID: 15057412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inner ear symptoms and disease: pathophysiological understanding and therapeutic options.
    Ciuman RR
    Med Sci Monit; 2013 Dec; 19():1195-210. PubMed ID: 24362017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine for Inner Ear Diseases: A Review of Recent
    Kim DK
    Biomed Res Int; 2017; 2017():3098230. PubMed ID: 29130038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inner ear immunology and allergy: an overview of current day concepts.
    Paleri V
    Ear Nose Throat J; 1997 Nov; 76(11):799-802, 807-8, 810 passim. PubMed ID: 9397627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.